‹ All stocks
Oruka Therapeutics
ORKA · NASDAQ · Healthcare
$99.24
▲ $0.00 (0.00%)
Day range
$97.83 – $100.94
Year range
$25.23 – $115.52
Open
$98.51
Previous close
$99.24
Market cap
$6.73B
Volume (24h)
$42.4K
Volume (52w)
$4.21M
Performance
7D
▼ -9.37%
1M
▲ 33.25%
3M
▼ -9.52%
6M
▲ 69.10%
1Y
▲ 251.56%
YTD
▲ 251.06%
3Y
▲ 342.27%
5Y
▲ 261.15%
All-time
▼ -100.00%
Key statistics
P/E ratio
-47.04
EPS (TTM)
$-2.11
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
67.8M
About Oruka Therapeutics
Oruka Therapeutics, Inc. functions as a biotechnology firm primarily dedicated to creating groundbreaking monoclonal antibody therapies. These treatments are designed to address Psoriasis (PsO) along with various other inflammatory and immunological (I&I) conditions. Its current development portfolio includes ORKA-001 and ORKA-002. The company's main operations are based in Menlo Park, CA.
Visit websiteCountry: United States of America
More in Healthcare
LLY Eli Lilly and Company |
$1405.83 | -1.81% |
JNJ Johnson & Johnson |
$278.83 | -1.32% |
ABBV AbbVie |
$292.60 | -0.66% |
MRK Merck & Co. |
$143.45 | -0.70% |
UNH UnitedHealth Group Incorp… |
$392.83 | -4.66% |